Enveric Biosciences
ENVB
ENVB
14 hedge funds and large institutions have $283K invested in Enveric Biosciences in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$44.8K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
$125K |
| 3 |
Morgan Stanley
New York
|
$15.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$34.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
$3.58K |
Top Sellers
| 1 |
HF
HRT Financial
New York
|
$0 |
| 2 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
UBS Group
Zurich,
Switzerland
|
$33.1K |
| 4 |
VF
Virtu Financial
New York
|
$25K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$0 |
